Search Within

Manickam Janakiraman

  1. "2011"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Genitourinary Oncology Service (7)
  4. Human Oncology and Pathogenesis Program (7)
  5. Solid Tumor Oncology Division (7)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. David Solit (7)
  2. Yogindra Persaud (3)
  3. Adriana Heguy (2)
  4. Barry Taylor (2)
  5. Bernard Bochner (2)
  6. Christine Pratilas (2)

More People

Years
  1. 2011 (7)
Publications
  1. Cancer Research (3)
  2. Journal of Pathology (1)
  3. Laboratory Investigation (1)
  4. Modern Pathology (1)
  5. Nature (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (2)
  3. Nature Research (1)
  4. Wiley Blackwell (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of the PTEN and RB1 tumor suppressors attenuates RAF-dependence in melanomas
    Meeting Abstract

    Xing, F.; Persaud, Y.; Pratilas, C. A.; Taylor, B. S.; Janakiraman, M.; She, Q. B.; Cobrinik, D.; Solit, D. B.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • An in-frame deletion in the N-terminal regulatory domain of BRAF(V600E) causes resistance to the RAF inhibitor PLX4032
    Meeting Abstract

    Poulikakos, P. I.; Persaud, Y.; Gabay, M. T.; Janakiraman, M.; Joseph, E. W.; Pratilas, C. A.; Chapman, P. B.; Rosen, N.; Solit, D. B.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Genomic analysis of high grade bladder cancer: Defining genetic subtypes and therapeutic targets
    Meeting Abstract

    Iyer, G.; Al-Ahmadie, H.; Taylor, B. S.; Janakiraman, M.; Lin, O.; Socci, N. D.; Heguy, A.; Viale, A.; Bochner, B.; Bajorin, D.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
    Journal Article

    Poulikakos, P. I.; Persaud, Y.; Janakiraman, M.; Kong, X.; Ng, C.; Moriceau, G.; Shi, H.; Atefi, M.; Titz, B.; Gabay, M. T.; more...
    Nature (2011)

    Fulltext@MSK | Save
  • Analysis of KRAS, NRAS, BRAF and PIK3CA mutations in matched primary and metastatic colorectal carcinomas
    Meeting Abstract

    Vakiani, E.; Janakiraman, M.; Shia, J.; Saltz, L.; Kemeny, N.; Weiser, M.; Solit, D.
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • Analysis of KRAS, NRAS, BRAF and PIK3CA mutations in matched primary and metastatic colorectal carcinomas
    Meeting Abstract

    Vakiani, E.; Janakiraman, M.; Shia, J.; Saltz, L.; Kemeny, N.; Weiser, M.; Solit, D.
    Laboratory Investigation (2011)

    Fulltext@MSK | Save
  • Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Journal Article

    Al-Ahmadie, H. A.; Iyer, G.; Janakiraman, M.; Lin, O.; Heguy, A.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Balar, A.; more...
    Journal of Pathology (2011)

    Fulltext@MSK | Save